Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies

Published:2020-07-05 Issue:8 Volume:66 Page:1104-1106
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Favresse Julien¹²,Eucher Christine¹,Elsen Marc¹,Tré-Hardy Marie²³⁴,Dogné Jean-Michel²,Douxfils Jonathan²⁵

Affiliation:

1. Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium

2. Department of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, Belgium

3. Department of Laboratory Medicine, Iris Hospitals South, Brussels, Belgium

4. Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium

5. Qualiblood sa, Namur, Belgium

Funder

Roche Diagnostics

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/advance-article-pdf/doi/10.1093/clinchem/hvaa131/33337437/hvaa131.pdf

Reference5 articles.

1. In vitro diagnostic assays for COVID-19: recent advances and emerging trends;Vashist;Diagnostics (Basel),2020

2. The important role of serology for COVID-19 control;Winter;Lancet Infect Dis,2020

3. SARS-CoV-2 serology: much hype, little data;Farnsworth;Clin Chem,2020

4. COVID-19 and postinfection immunity: limited evidence, many remaining questions;Kirkcaldy;JAMA

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine‐induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is immunogenicity equivalent?;Heliyon;2024-08

2. Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage;Journal of Infection and Chemotherapy;2024-07

3. Vaccine‐Induced Humoral Response of BNT162b2 and MRNA-1273 Against BA.1, BA.5, and XBB.1.5. (Sub)Variants 6 Months after a Homologous Booster: Is Immunogenicity Equivalent?;2024

4. Evaluation of Neutralizing Capacity of Tixagevimab plus Cilgavimab (AZD7442) against Different SARS‐CoV‐2 Variants: A Case Report Study with Comparison to a Vaccinated Population;Case Reports in Infectious Diseases;2024-01

5. Immunological tests: Essential and supportive tools in the fight against COVID-19;TrAC Trends in Analytical Chemistry;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3